-
1
-
-
77956065470
-
Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: Clinical recommendations
-
Frid A, Sterner GN, Löndahl M et al. Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations. Diabetes Care 2010; 33: 1291-1293
-
(2010)
Diabetes Care
, vol.33
, pp. 1291-1293
-
-
Frid, A.1
Sterner, G.N.2
Löndahl, M.3
-
2
-
-
0037347482
-
Measurement of metformin concentration in erythrocytes: Clinical implications
-
Lalau J, Lacroix C. Measurement of metformin concentration in erythrocytes: clinical implications. Diabetes Obes Metab 2003; 5: 92-98
-
(2003)
Diabetes Obes Metab
, vol.5
, pp. 92-98
-
-
Lalau, J.1
Lacroix, C.2
-
3
-
-
0038727578
-
Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects
-
Robert F, Fendri S, Hary L et al. Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects. Diabetes Metab 2003; 29: 279-283 (Pubitemid 36807438)
-
(2003)
Diabetes and Metabolism
, vol.29
, Issue.3
, pp. 279-283
-
-
Robert, F.1
Fendri, S.2
Hary, L.3
Lacroix, C.4
Andrejak, M.5
Lalau, J.D.6
-
4
-
-
77955566180
-
Lactic acidosis induced by oral antidiabetic drugs: Incidence, management and prevention
-
Lalau J. Lactic acidosis induced by oral antidiabetic drugs: incidence, management and prevention. Drug Saf 2010; 33: 727-740
-
(2010)
Drug Saf
, vol.33
, pp. 727-740
-
-
Lalau, J.1
-
5
-
-
0029933886
-
Clinical pharmacokinetics of metformin
-
Scheen A. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996; 30: 359-371 (Pubitemid 26177181)
-
(1996)
Clinical Pharmacokinetics
, vol.30
, Issue.5
, pp. 359-371
-
-
Scheen, A.J.1
-
6
-
-
33747120659
-
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
-
Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254 (Pubitemid 46768608)
-
(2006)
Annals of Internal Medicine
, vol.145
, Issue.4
, pp. 247-254
-
-
Levey, A.S.1
Coresh, J.2
Greene, T.3
Stevens, L.A.4
Zhang, Y.5
Hendriksen, S.6
Kusek, J.W.7
Van Lente, F.8
-
7
-
-
0025889909
-
Microassay of plasma and erythrocyte metformin by high performance liquid chromatography
-
Lacroix C, Danger P, Wojciechowski F. Microassay of plasma and erythrocyte metformin by high performance liquid chromatography. Ann Biol Clin (Paris) 1991; 2: 98-101
-
(1991)
Ann Biol Clin (Paris)
, vol.2
, pp. 98-101
-
-
Lacroix, C.1
Danger, P.2
Wojciechowski, F.3
-
8
-
-
79955615667
-
Establishment of a database of plasma and erythrocyte metformin concentrations in normal and emergency situations
-
Lalau J, Lemaire-Hurtel A, Lacroix C. Establishment of a database of plasma and erythrocyte metformin concentrations in normal and emergency situations. Clin Drug Investig 201131: 435-438
-
(2011)
Clin Drug Investig
, vol.31
, pp. 435-438
-
-
Lalau, J.1
Lemaire-Hurtel, A.2
Lacroix, C.3
-
9
-
-
0032917623
-
Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations
-
DOI 10.2165/00002018-199920040-00006
-
Lalau J, Race J. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999; 20: 377-384 (Pubitemid 29196913)
-
(1999)
Drug Safety
, vol.20
, Issue.4
, pp. 377-384
-
-
Lalau, J.-D.1
Race, J.-M.2
-
10
-
-
0037417580
-
Contraindications to the use of metformin Evidence suggests that it is time to amend the list
-
Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. Evidence suggests that it is time to amend the list. BMJ 2003; 326: 4-5
-
(2003)
BMJ
, vol.326
, pp. 4-5
-
-
Jones, G.C.1
Macklin, J.P.2
Alexander, W.D.3
-
11
-
-
24044478791
-
Metformins contraindications should be contraindicated
-
McCormack J, Johns K, Tildesley H. Metformins contraindications should be contraindicated. CAMJ 2005; 173: 502-504
-
(2005)
CAMJ
, vol.173
, pp. 502-504
-
-
McCormack, J.1
Johns, K.2
Tildesley, H.3
-
12
-
-
52649168930
-
Metformin: Effective and safe in renal disease?
-
Herrington WG, Levy JB. Metformin: effective and safe in renal disease? Int Urol Nephrol 2008; 40: 411-417
-
(2008)
Int Urol Nephrol
, vol.40
, pp. 411-417
-
-
Herrington, W.G.1
Levy, J.B.2
-
13
-
-
77952911680
-
Metformin: Potential benefits and use in chronic kidney disease
-
Pilmore H. Metformin: potential benefits and use in chronic kidney disease. Nephrology (Carlton) 2010; 15: 412-418
-
(2010)
Nephrology (Carlton)
, vol.15
, pp. 412-418
-
-
Pilmore, H.1
|